Healthstream Inc income statement
In fiscal 2025, Healthstream Inc reported revenue of $304m, up 4.3% on the year before, operating income of $20.2m (a 6.7% margin) and net income of $18.3m, or $0.61 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.
Income statement
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 57 | 66 | 82 | 104 | 132 | 171 | 209 | 192 | 215 | 232 | 254 | 245 | 257 | 267 | 279 | 292 | 304 | 321 |
| Cost of revenue | 21 | 24 | 31 | 42 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Gross profit | 36 | 42 | 51 | 62 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Research and development | 6 | 7 | 7 | 9 | 12 | 16 | 24 | 24 | 24 | 26 | 29 | 32 | 42 | 44 | 46 | 49 | 51 | 54 |
| Selling and marketing | 11 | 13 | 16 | 20 | 24 | 30 | 36 | 35 | 39 | 36 | 38 | 35 | 39 | 44 | 46 | 47 | 49 | 52 |
| General and administrative | 9 | 10 | 11 | 13 | 18 | 23 | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating income | 5 | 7 | 11 | 13 | 15 | 16 | 14 | 7 | 9 | 15 | 15 | 16 | 8 | 12 | 16 | 21 | 20 | 26 |
| Income before tax | 5 | 7 | 11 | 14 | 15 | 17 | 14 | 8 | 10 | 17 | 18 | 18 | 8 | 16 | 19 | 25 | 23 | 28 |
| Income tax | −9 | 3 | 4 | 6 | 6 | 6 | 5 | 3 | 1 | 3 | 4 | 4 | 2 | 3 | 3 | 5 | 5 | 6 |
| Net income | 14 | 4 | 7 | 8 | 8 | 10 | 9 | 4 | 10 | 32 | 16 | 14 | 6 | 12 | 15 | 20 | 18 | 21 |
| Diluted EPS | $0.64 | $0.18 | $0.29 | $0.28 | $0.30 | $0.37 | $0.28 | $0.12 | $0.31 | $1.00 | $0.49 | $0.44 | $0.18 | $0.39 | $0.50 | $0.66 | $0.61 | $0.72 |
| Diluted shares (average) | — | 22m | 24m | 28m | 28m | 28m | 30m | 32m | 32m | 32m | 32m | 32m | 32m | 31m | 31m | 31m | 30m | 30m |
| EBITDA | 10 | 12 | 17 | 20 | 23 | 27 | 31 | 28 | 33 | 40 | 43 | 46 | 45 | 50 | 57 | 63 | 64 | 70 |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 73 | 74 | 73 | 74 | 76 | 80 | 81 | 84 |
| Research and development | 12 | 13 | 12 | 12 | 12 | 15 | 14 | 14 |
| Selling and marketing | 11 | 12 | 12 | 12 | 12 | 13 | 13 | 14 |
| Operating income | 6 | 5 | 4 | 6 | 8 | 2 | 8 | 8 |
| Income before tax | 7 | 5 | 5 | 7 | 8 | 3 | 8 | 9 |
| Income tax | 2 | 1 | 1 | 1 | 2 | 0 | 2 | 2 |
| Net income | 6 | 5 | 4 | 5 | 6 | 3 | 6 | 7 |
| Diluted EPS | $0.19 | $0.16 | $0.14 | $0.18 | $0.20 | $0.09 | $0.20 | $0.23 |
| EBITDA | 17 | 15 | 15 | 17 | 18 | 13 | 19 | 20 |
Compare with peers
- Health Catalyst, Inc. income statement
- Definitive Healthcare Corp. income statement
- Genedx Holdings Corp. income statement
- American Well Corp income statement
- Phreesia, Inc. income statement
Head to head: HCAT vs HSTMDH vs HSTMHSTM vs WGSAMWL vs HSTM
More: Health Care Technology stocks compared, Health Care sector, rankings of US companies